Please try another search
Shenyang Xingqi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of ophthalmic medications in the People’s Republic of China. The company offers corneal, anti-bacteria, artificial tears, anti-inflammation, anti-allergic, mydriactics, anti-fatigue, and dry eye treatment products. It also engages in the technology development, technical consultation, investment, and eye hospital businesses, as well as production and wholesale of pharmaceuticals. The company was founded in 1977 and is headquartered in Shenyang, the People’s Republic of China.
Name | Age | Since | Title |
---|---|---|---|
Qiang Yang | 39 | 2017 | Head of R&D, Deputy GM & Director |
E. Gao | 49 | 2011 | GM & Non-Independent Director |
Yanan Cheng | 49 | 2018 | CFO & Non-Independent Director |
Shao Yao Zhang | 53 | 2015 | Deputy Chairman, Deputy GM & Secretary of the Board |
Qi Xu | 33 | 2021 | Chairman of the Supervisory Board |
- Newsun | 66 | 2023 | Chairman of the Board |
Jidong Liu | 67 | 2024 | Non-Independent Director |
Di Li | 68 | 2018 | Independent Director |
Xiaobin Dai | 67 | 2021 | Independent Director |
Zhongcheng Wang | 48 | 2018 | Independent Director |
Xiaoyu Qu | 37 | 2021 | Non-Employee Supervisor |
Xiaoyan Kong | - | 2024 | Independent Director |
Chunhua Li | 47 | 2022 | Director |
Xianmei Xu | - | 2024 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review